Immunological and genetic features of pathogenetic association between psoriasis and colonic dysbiosis

Immunological and genetic features of pathogenetic association between psoriasis and colonic dysbiosis

Psoriasis is a multifactorial systemic immune-associated disease. It is assumed that colonic dysbiosis may contribute to its development. In this review we provide the data on colonic dysbiosis in induction and progression of psoriatic inflammation assessing a role for bacterial species: Akkermansia...

Full description

Bibliographic Details
Main Authors:	A. A. Goncharov, O. V. Dolgikh
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2021-03-01
Series:	Инфекция и иммунитет
Subjects:	autoimmunity single nucleotide polymorphisms psoriasis colonic microbiota akkermansia muciniphila escherichia coli faecalibacterium prausnitzii streptococcus pyogenes
Online Access:	https://www.iimmun.ru/iimm/article/view/1277

Similar Items

Alterations of gut bacteria Akkermansia muciniphila and Faecalibacterium prausnitzii in late post-transplant period after liver transplantation
by: Alexander Kukov, et al.
Published: (2022-01-01)

Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
by: Theodor Brodmann, et al.
Published: (2017-09-01)

Next-generation probiotics – do they open new therapeutic strategies for cancer patients?
by: Karolina Kaźmierczak-Siedlecka, et al.
Published: (2022-12-01)

Characteristics of the microbiome in patients with symptomatic uncomplicated colonic diverticular disease in the central region of Ukraine
by: A. E. Dorofieiev, et al.
Published: (2023-07-01)

<i>Akkermansia muciniphila</i> and <i>Faecalibacterium prausnitzii</i> in Immune-Related Diseases
by: Raden Mohamad Rendy Ariezal Effendi, et al.
Published: (2022-11-01)

Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases
by: Mingxia Bi, et al.
Published: (2023-06-01)

Next-generation probiotics: Health-promoting bacteria of the human gut
by: Golić Nataša, et al.
Published: (2023-01-01)

A Two-Step Single Plex PCR Method for Evaluating Key Colonic Microbiota Markers in Young Mexicans with Autism Spectrum Disorders: Protocol and Pilot Epidemiological Application
by: Julián Herrera-Mejía, et al.
Published: (2023-07-01)

Effect of High versus Low Dairy Consumption on the Gut Microbiome: Results of a Randomized, Cross-Over Study
by: J. Casper Swarte, et al.
Published: (2020-07-01)

Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate with immune-modulating function
by: Hong Ki Min, et al.
Published: (2023-04-01)

Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
by: Xiaoying Hou, et al.
Published: (2021-09-01)

Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community
by: Kevin D'hoe, et al.
Published: (2018-10-01)

The First Report of Differences in Gut Microbiota Composition between Obese and Normal Weight Iranian Subjects
by: Fateme Ettehad Marvasti, et al.
Published: (2020-05-01)

Microbiota-specific CD4CD8αα Tregs: role in intestinal immune homeostasis and implications for IBD
by: Guillaume eSARRABAYROUSE, et al.
Published: (2015-10-01)

Modulation of Mucosal Immune Response, Tolerance and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila
by: Muriel eDerrien, et al.
Published: (2011-08-01)

The Differential Expression of the Inflammasomes in Adipose Tissue and Colon Influences the Development of Colon Cancer in a Context of Obesity by Regulating Intestinal Inflammation
by: Frühbeck G, et al.
Published: (2021-12-01)

The Differential Expression of the Inflammasomes in Adipose Tissue and Colon Influences the Development of Colon Cancer in a Context of Obesity by Regulating Intestinal Inflammation [Corrigendum]
by: Frühbeck G, et al.
Published: (2023-03-01)

Pyruvate: Ferredoxin oxidoreductase is involved in IgA-related microbiota dysbiosis and intestinal inflammation
by: Kairuo Wang, et al.
Published: (2022-12-01)

1-Kestose, the Smallest Fructooligosaccharide Component, Which Efficiently Stimulates Faecalibacterium prausnitzii as Well as Bifidobacteria in Humans
by: Takumi Tochio, et al.
Published: (2018-09-01)

A metagenome-wide association study of gut microbiota in asthma in UK adults
by: Qi Wang, et al.
Published: (2018-09-01)

The importance of Faecalibacterium prausnitzii in human health and diseases
by: M. Parsaei, et al.
Published: (2021-09-01)

Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
by: Tatiani Uceli Maioli, et al.
Published: (2021-12-01)

On neotypes and nomina nova: commentary on “Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa”, by C.B. Fitzgerald et al. (BMC Genomics (2018) 19:931)
by: Aharon Oren, et al.
Published: (2020-04-01)

Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe
by: Hai-Tao Yang, et al.
Published: (2024-01-01)

Consumption of kiwifruit capsules increases Faecalibacterium prausnitzii abundance in functionally constipated individuals: a randomised controlled human trial
by: Paul Blatchford, et al.
Published: (2017-01-01)

Modulation of the Caecal Gut Microbiota of Mice by Dietary Supplement Containing Resistant Starch: Impact Is Donor-Dependent
by: Claire Cherbuy, et al.
Published: (2019-06-01)

A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents
by: Sofia Moran-Ramos, et al.
Published: (2021-09-01)

Isolation and characterization of Faecalibacterium prausnitzii extracellular vesicles
by: B Jafari, et al.
Published: (2017-11-01)

The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps
by: Douglas Hanes, et al.
Published: (2022-09-01)

Global scientific output trend for Akkermansia muciniphila research: a bibliometric and scientometric analysis
by: Hojat Dehghanbanadaki, et al.
Published: (2020-11-01)

Akkermansia muciniphila Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis
by: Tuo Chen, et al.
Published: (2021-10-01)

<i>Akkermansia muciniphila</i> Reduces Peritonitis and Improves Intestinal Tissue Wound Healing after a Colonic Transmural Defect by a MyD88-Dependent Mechanism
by: Radu Bachmann, et al.
Published: (2022-08-01)

<i>Akkermansia muciniphila</i> Ameliorates Alcoholic Liver Disease in Experimental Mice by Regulating Serum Metabolism and Improving Gut Dysbiosis
by: Cheng Fang, et al.
Published: (2023-10-01)

AG1<sup>®</sup> Induces a Favorable Impact on Gut Microbial Structure and Functionality in the Simulator of Human Intestinal Microbial Ecosystem<sup>®</sup> Model
by: Trevor O. Kirby, et al.
Published: (2024-01-01)

Differences in Gut Microbiome Composition between Senior Orienteering Athletes and Community-Dwelling Older Adults
by: Frida Fart, et al.
Published: (2020-08-01)

Metabolic Response of <i>Faecalibacterium prausnitzii</i> to Cell-Free Supernatants from Lactic Acid Bacteria
by: Mathilde Lebas, et al.
Published: (2020-10-01)

Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from <i>Faecalibacterium prausnitzii</i>
by: Sandrine Auger, et al.
Published: (2022-02-01)

Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
by: Li-ting Jin, et al.
Published: (2023-01-01)

A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn’s Disease
by: Songhe Guo, et al.
Published: (2019-06-01)

Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences
by: L. Berbert, et al.
Published: (2022-03-01)